Naser Ahmadbeigi
- Genetics top 2%
- Mesenchymal stem cell research 27
- Virus-based gene therapy research 11
- Urology top 2%
- Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications 10
- Oncology top 10%
- CAR-T cell therapy research 17
- Rheumatology top 10%
-
- Tissue Engineering and Regenerative Medicine 12
-
- Hematopoietic Stem Cell Transplantation 11
-
- MicroRNA in disease regulation 5
-
- CRISPR and Genetic Engineering 5
- Co-authors
- Masoud SoleimaniVahid MansouriAbbas ShafieeEhsan SeyedjafariYousof GheisariMahmood NaderiAzadeh OmidkhodaMohammad Vasei
- Cited by
- GeneticsUrologyBiomaterials
- Journals
- Nucleic Acids Research (1 paper)SHILAP Revista de lepidopterología (2 papers)The Journal of Urology (1 paper)
- Partner nations
- IranBrazilUnited States
In The Last Decade
Naser Ahmadbeigi
59 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Genetics 497
- Urology 175
- Biomaterials 238
- Oncology 272
- Rheumatology 147
Countries citing papers authored by Naser Ahmadbeigi
This map shows the geographic impact of Naser Ahmadbeigi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser Ahmadbeigi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser Ahmadbeigi more than expected).
Fields of papers citing papers by Naser Ahmadbeigi
This network shows the impact of papers produced by Naser Ahmadbeigi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser Ahmadbeigi. The network helps show where Naser Ahmadbeigi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naser Ahmadbeigi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 12 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 6 | |
| 8 | Gene therapy clinical trials, where do we go? An overviewbreakdown → | 2022 | 148 |
| 9 | 2019 | 8 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 4 | |
| 12 | Draft of Iranian National Guideline for Cell Therapy Manufacturing. | 2017 | 6 |
| 13 | 2016 | 5 | |
| 14 | ISOLATION AND CHARACTERIZATION OF HEMATOPOIETIC AND MESENCHYMAL STEM CELLS DERIVED FROM HUMAN PLACENTA TISSUE | 2014 | 0 |
| 15 | 2013 | 19 | |
| 16 | The Efficiency of Density Gradient for Separation of Mesenchymal Stem Cells from Bone Marrow Sample | 2011 | 0 |
| 17 | 2011 | 70 | |
| 18 | 2010 | 24 | |
| 19 | 2008 | 128 | |
| 20 | 2008 | 65 |
About Naser Ahmadbeigi
Naser Ahmadbeigi is a scholar working on Genetics, Hematology and Oncology, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (27 papers), CAR-T cell therapy research (17 papers), Tissue Engineering and Regenerative Medicine (12 papers), Virus-based gene therapy research (11 papers), Hematopoietic Stem Cell Transplantation (11 papers), Electrospun Nanofibers in Biomedical Applications (10 papers), MicroRNA in disease regulation (5 papers) and CRISPR and Genetic Engineering (5 papers). The work is most often cited by research in Genetics (497 citations), Urology (175 citations) and Biomaterials (238 citations). Naser Ahmadbeigi has collaborated with scholars based in Iran, Brazil and United States. Frequent co-authors include Masoud Soleimani, Vahid Mansouri, Abbas Shafiee, Ehsan Seyedjafari, Yousof Gheisari, Mahmood Naderi, Azadeh Omidkhoda, Mohammad Vasei, Peyman Dinarvand and Nasser Ghaemi. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.